Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD8154 Following Single Ascending Dose Administration in Healthy Subjects

Trial Profile

A Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD8154 Following Single Ascending Dose Administration in Healthy Subjects

Recruiting
Phase of Trial: Phase I

Latest Information Update: 02 Jan 2019

At a glance

  • Drugs AZD-8154 (Primary)
  • Indications Asthma
  • Focus Adverse reactions; First in man
  • Sponsors AstraZeneca
  • Most Recent Events

    • 21 Dec 2019 Planned End Date changed from 16 Jan 2019 to 30 Apr 2019.
    • 21 Dec 2019 Planned primary completion date changed from 16 Jan 2019 to 30 Apr 2019.
    • 31 Aug 2018 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top